Biotechnology Regulatory Services

The Department of Agriculture Animal and Plant Health Inspection Service Biotechnology Regulatory Services is a civilian sub-agency that manages regulatory compliance and inspection services for agricultural biotechnology products and research. APHIS Biotechnology Regulatory Services procures contract support for regulatory analysis, permitting infrastructure, inspection protocols, and compliance documentation across domestic and international agricultural biotechnology activities.

APHIS Biotechnology Regulatory Services has awarded 40 federal contracts since 2010, with combined potential value of $3.1 million and combined dollars obligated of $3 million (95% of potential value). Contract activity has remained modest and steady: 5 awards in 2020, 1 in 2021, 6 in 2022, 5 in 2023, and 5 in 2024. The most recent award closed on September 2, 2024. Among 20 distinct prime contractors awarded across the portfolio, competitive concentration is moderately concentrated in the last five years. Accenture Federal Services LLC leads by combined potential value at $1.1 million (1 award) and holds 52% of recent potential value across the top five vendors. By award count, Salmon Group Inc. leads with 6 awards totaling $45 thousand combined potential value, followed by Salmon JV Inc. and New TECH Solutions, Inc., each with 3 awards. These top five primes account for 88% of recent awards by count.

The contracting profile is heavily skewed toward unrestricted competition: 93% of awards carry no set-aside designation, with only 3 small-business set-aside awards (8% of total). The dollar scale of individual awards is modest — the largest single award to Accenture Federal Services totals $1.1 million, while most other awards fall well below $100 thousand. The agency transacts through a mix of contract vehicles; the low reported value density relative to award count suggests Schedule task orders, BPA calls, or below-threshold purchase orders constitute a portion of the portfolio.

No recent federal contract opportunities are recorded against APHIS Biotechnology Regulatory Services in the most recent opportunities block. No grant activity or grant opportunities are present in the source data.